Male Infertility Industry Data Book - Male Infertility Diagnosis and Male Infertility Treatment Market Size, Share, Trends Analysis, and Segment Forecasts, 2023 - 2030
The global Male Infertility Industry was estimated at USD 4.03 billion in 2022 and is expanding at a significant CAGR of 4.95% from 2023 to 2030, according to a new report by Grand View Research, Inc.
Grand View Research’s male infertility industry data book is a collection of market sizing information & forecasts, trade data, pricing intelligence, competitive benchmarking analyses, macro-environmental analyses, and regulatory & technological framework studies. Within the purview of the database, such information is systematically analyzed and provided in the form of outlook reports and summary presentations on individual areas of research along with a digital healthcare statistics e-book.
Access the Global Male Infertility Industry Data Book, 2023 to 2030, compiled with details like market sizing information & forecasts, trade data, pricing intelligence, competitive benchmarking, macro-environmental analyses, and regulatory & technological framework studies
Male Infertility Diagnosis Market Growth & Trends
The global Male Infertility Diagnosis size was valued at USD 343.8 million in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 5.89% from 2023 to 2030. A study published in the Journal of Urology in 2020 mentioned that the prevalence of male infertility in the U.S. was around 15%. This can be attributed to the increase in consumption of alcohol, smoking, obesity, stress, and lifestyle changes. Studies have shown that smoking can damage sperm DNA, reduce sperm motility & count, and increase the percentage of abnormal sperm. It can also lead to erectile dysfunction and decreased libido. Smoking can also affect the success rate of ARTs, such as IVF. Thus, as a result of the abovementioned factors, the increasing incidence of infertility is expected to help the market grow. Microscopic examination is an important diagnostic test for male infertility. It involves the analysis of a semen sample under a microscope to evaluate the quantity, quality, and motility of sperm. The test can help identify issues such as low sperm count, poor sperm motility, and abnormal sperm morphology.
Based on diagnosis techniques, DNA fragmentation test accounted for the largest share of 21.76% of the diagnosis market in 2022, due to its ability to provide reliable analysis of sperm DNA integrity. It is also expected to exhibit the strongest growth during the forecast period. The manual method is still widely used for semen analysis in developing economies. However, this method is expected to be replaced by computer-assisted semen analysis in the coming years.
Order your copy of the Free Sample of “Male Infertility Industry Data Book - Male Infertility Diagnosis and Male Infertility Treatment Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030” Data Book, published by Grand View Research
Male Infertility Treatment Market Growth & Trends
The global male infertility treatment market is valued at USD 3.68 billion as of 2022 and is expected to expand at a CAGR of 4.86% for the forecast period 2023-2030. High adoption of Assisted Reproductive Technology (ART) is a significant driver for the male infertility market. The increasing awareness and acceptance of ART have led to a surge in demand for these procedures. According to a report by the Centers for Disease Control and Prevention (CDC), the use of ART has doubled in the past decade in the U.S. alone.
In 2022, ART dominated the market with a revenue share of 71.11% and is likely to maintain its lead during the forecast period. Drugs and hormonal therapy are preferred for initial treatment. ART is usually preferred in case treatment with medication fails.
Furthermore, advancements in technology and techniques have significantly improved the success rate of ART procedures. For instance, the use of Preimplantation Genetic Testing (PGT) has resulted in higher success rates of IVF procedures by helping identify chromosomally normal embryos. Hence, as a result of the aforementioned factors, the male infertility market may grow over the forecast period.
Competitive Landscape
Key players operating in the Male Infertility industry are:
- EMD Serono, Inc.
- Endo International plc
- Sanofi
- Bayer Group
- SCSA Diagnostics
Check out more Industry Data Books, published by Grand View Research
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: https://www.grandviewresearch.com/sector-reports-list
Follow Us: LinkedIn | Twitter
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek